LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

Search

Atara Biotherapeutics Inc

Open

SectorHealthcare

10.24 6.56

Overview

Share price change

24h

Current

Min

9.02

Max

10.29

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+58% upside

Dividends

By Dow Jones

Next Earnings

14 May 2026

News Sentiment

By Acuity

60%

40%

286 / 346 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Atara Biotherapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Jan 2026, 15:39 UTC

Major Market Movers

Atara Biotherapeutics Stock Falls After Surprise FDA Refusal to Approve Ebvallo

Peer Comparison

Price change

Atara Biotherapeutics Inc Forecast

Price Target

By TipRanks

58% upside

12 Months Forecast

Average 15.5 USD  58%

High 18 USD

Low 13 USD

Based on 2 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

7.245 / 7.64Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

286 / 346 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$

help-icon Live chat